BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 22014776)

  • 1. Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia.
    Kozic JR; Benton SJ; Hutcheon JA; Payne BA; Magee LA; von Dadelszen P;
    J Obstet Gynaecol Can; 2011 Oct; 33(10):995-1004. PubMed ID: 22014776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Liver Enzymes in Cases of Preeclampsia and Intrauterine Growth Restriction.
    Dacaj R; Izetbegovic S; Stojkanovic G; Dreshaj S
    Med Arch; 2016 Feb; 70(1):44-7. PubMed ID: 26980931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review.
    Thangaratinam S; Koopmans CM; Iyengar S; Zamora J; Ismail KM; Mol BW; Khan KS;
    Acta Obstet Gynecol Scand; 2011 Jun; 90(6):574-85. PubMed ID: 21355861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver function tests in pre-eclampsia: importance of comparison with a reference range derived for normal pregnancy.
    Girling JC; Dow E; Smith JH
    Br J Obstet Gynaecol; 1997 Feb; 104(2):246-50. PubMed ID: 9070148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using clinical symptoms to predict adverse maternal and perinatal outcomes in women with preeclampsia: data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) study.
    Yen TW; Payne B; Qu Z; Hutcheon JA; Lee T; Magee LA; Walters BN; von Dadelszen P;
    J Obstet Gynaecol Can; 2011 Aug; 33(8):803-809. PubMed ID: 21846435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxygen saturation as a predictor of adverse maternal outcomes in women with preeclampsia.
    Millman AL; Payne B; Qu Z; Joanne Douglas M; Hutcheon JA; Lee T; Magee LA; Walley KR; von Dadelszen P;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):705-714. PubMed ID: 21749746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model.
    von Dadelszen P; Payne B; Li J; Ansermino JM; Broughton Pipkin F; Côté AM; Douglas MJ; Gruslin A; Hutcheon JA; Joseph KS; Kyle PM; Lee T; Loughna P; Menzies JM; Merialdi M; Millman AL; Moore MP; Moutquin JM; Ouellet AB; Smith GN; Walker JJ; Walley KR; Walters BN; Widmer M; Lee SK; Russell JA; Magee LA;
    Lancet; 2011 Jan; 377(9761):219-27. PubMed ID: 21185591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are maternal and fetal parameters related to perinatal mortality in HELLP syndrome?
    Guzel AI; Kuyumcuoglu U; Celik Y
    Arch Gynecol Obstet; 2011 Jun; 283(6):1227-32. PubMed ID: 20526778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. May maternal anti-mullerian hormone levels predict adverse maternal and perinatal outcomes in preeclampsia?
    Tokmak A; Güney G; Aksoy RT; Guzel AI; Topcu HO; Keçecioğlu TS; Uygur D
    J Matern Fetal Neonatal Med; 2015 Aug; 28(12):1451-6. PubMed ID: 25133554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinuria in pre-eclampsia: how much matters?
    Chan P; Brown M; Simpson JM; Davis G
    BJOG; 2005 Mar; 112(3):280-5. PubMed ID: 15713140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased concentrations of lactate dehydrogenase in pregnancy with preeclampsia: a predictor for the birth of small-for-gestational-age infants.
    He S; Bremme K; Kallner A; Blombäck M
    Gynecol Obstet Invest; 1995; 39(4):234-8. PubMed ID: 7635366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of alanine aminotransferase/aspartate aminotransferase ratio and high-density lipoprotein for predicting neonatal adverse outcomes associated with intrahepatic cholestasis of pregnancy.
    Fan X; Li X; Yu T; Jiao R; Song W; Su A; Li M; Guo Q
    PeerJ; 2024; 12():e17613. PubMed ID: 38938614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current CHS and NHBPEP criteria for severe preeclampsia do not uniformly predict adverse maternal or perinatal outcomes.
    Menzies J; Magee LA; Macnab YC; Ansermino JM; Li J; Douglas MJ; Gruslin A; Kyle P; Lee SK; Moore MP; Moutquin JM; Smith GN; Walker JJ; Walley KR; Russell JA; von Dadelszen P
    Hypertens Pregnancy; 2007; 26(4):447-62. PubMed ID: 18066963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prediction of adverse maternal outcomes in preeclampsia.
    von Dadelszen P; Magee LA; Devarakonda RM; Hamilton T; Ainsworth LM; Yin R; Norena M; Walley KR; Gruslin A; Moutquin JM; Lee SK; Russell JA
    J Obstet Gynaecol Can; 2004 Oct; 26(10):871-9. PubMed ID: 15507197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential plasma angiogenic factors levels in women with suspected preeclampsia.
    Baltajian K; Bajracharya S; Salahuddin S; Berg AH; Geahchan C; Wenger JB; Thadhani R; Karumanchi SA; Rana S
    Am J Obstet Gynecol; 2016 Jul; 215(1):89.e1-89.e10. PubMed ID: 26827880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer.
    Liu X; Meng QH; Ye Y; Hildebrandt MA; Gu J; Wu X
    Carcinogenesis; 2015 Feb; 36(2):243-8. PubMed ID: 25524924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemolysis, elevated liver enzymes, and low platelet syndrome: Outcomes for patients admitted to intensive care at a tertiary referral hospital.
    Gedik E; Yücel N; Sahin T; Koca E; Colak YZ; Togal T
    Hypertens Pregnancy; 2017 Feb; 36(1):21-29. PubMed ID: 27599183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal liver function tests in acute heart failure: relationship with clinical characteristics and outcome in the PROTECT study.
    Biegus J; Hillege HL; Postmus D; Valente MA; Bloomfield DM; Cleland JG; Cotter G; Davison BA; Dittrich HC; Fiuzat M; Givertz MM; Massie BM; Metra M; Teerlink JR; Voors AA; O'Connor CM; Ponikowski P
    Eur J Heart Fail; 2016 Jul; 18(7):830-9. PubMed ID: 27170455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uric Acid as a predictor of adverse maternal and perinatal outcomes in women hospitalized with preeclampsia.
    Livingston JR; Payne B; Brown M; Roberts JM; Côté AM; Magee LA; von Dadelszen P;
    J Obstet Gynaecol Can; 2014 Oct; 36(10):870-877. PubMed ID: 25375299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated liver enzymes and adverse outcomes among patients with preeclampsia with severe features.
    Greiner KS; Rincón M; Derrah KL; Burwick RM
    J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2160627. PubMed ID: 36597834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.